← Back to Clinical Trials
Recruiting NCT06235502

NCT06235502 Long-term Home-based Exercise for Patients With COPD: the COPDtoParis Project

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06235502
Status Recruiting
Phase
Sponsor Aalborg University Hospital
Condition Telerehabilitation
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2023-11-01
Primary Completion 2025-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Home-based cycle-exercise for COPD patientsStandard of Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2023-11-01 with a primary completion date of 2025-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomised controlled trial (RCT) aims to investigate the effect of long-term, interactive home-based cycle-exercise on patients with Chronic Obstructive Pulmonary Disease (COPD) after a COPD exacerbation requiring hospitalisation. The investigators aim to investigate if patients can maintain or improve the effects of pulmonary rehabilitation in terms of walking distance, intensity of COPD symptoms, health related quality of life and Quality Adjusted Life-Years. Participants will cycle on a pedal-exerciser in the comfort of staying in the participants' own home, whilst getting visual feedback from the 4Mvideo app. The 4Mvideo technology is a Danish designed software system, where users can cycle forward a recording of a cyclist by treading on a pedal-exerciser, thereby getting some of the experience of a real-life cycling trip at home. The investigators will compare the clinical outcomes and daily activity levels with that of a control group consisting of COPD patients.

Eligibility Criteria

Inclusion Criteria: * Adults at age \> 18 years old * Hospital admission with COPD exacerbation with pre-existing COPD diagnosis * Citizens of Aalborg Municipality * Able to provide informed consent * Accepting of referral to rehabilitation Exclusion Criteria: * Terminal illness * Unstable heart disease, i.e., ischemic heart disease, cardiac rhythm disorders * Other conditions preventing participating in cycle exercise, e.g., amputation, regimens or earlier or upcoming surgeries preventing seated position, blindness * Inability to understand basic Danish oral and written information or giving informed consent.

Contact & Investigator

Central Contact

Anna L Stoustrup, MSc

✉ a.stoustrup@rn.dk

📞 +45 52505879

Principal Investigator

Anna L Stoustrup, MSc

PRINCIPAL INVESTIGATOR

a.stoustrup@rn.dk

Frequently Asked Questions

Who can join the NCT06235502 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Telerehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06235502 currently recruiting?

Yes, NCT06235502 is actively recruiting participants. Contact the research team at a.stoustrup@rn.dk for enrollment information.

Where is the NCT06235502 trial being conducted?

This trial is being conducted at Aalborg, Denmark.

Who is sponsoring the NCT06235502 clinical trial?

NCT06235502 is sponsored by Aalborg University Hospital. The principal investigator is Anna L Stoustrup, MSc at a.stoustrup@rn.dk. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology